Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma

被引：0
作者：
Bin Yu
Youming Ding
Xiaofeng Liao
Changhua Wang
Bin Wang
Xiaoyan Chen
机构：
[1] Renmin Hospital of Wuhan University,Department of Hepatobiliary and Laparoscopic Surgery
[2] Xiangyang Central Hospital,Department of General Surgery
[3] Wuhan University School of Basic Medical Sciences,Department of Pathology and Pathophysiology
来源：
Digestive Diseases and Sciences | 2019年 / 64卷
关键词：
Hepatocellular carcinoma; PARPBP; PARI; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2878 / 2892
页数：14
相关论文
共 96 条
  • [1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
  • [2] Ferlay J(2017)Medical management of hepatocellular carcinoma J Oncol Pract 13 356-364
  • [3] Soerjomataram I(2016)Survivin in survival of hepatocellular carcinoma Cancer Lett 379 184-190
  • [4] Rich NE(2013)PARI overexpression promotes genomic instability and pancreatic tumorigenesis Cancer Res 73 2529-2539
  • [5] Yopp AC(2012)Inhibition of homologous recombination by the PCNA-interacting protein PARI Mol Cell 45 75-86
  • [6] Singal AG(2011)C12orf48, termed PARP-1 binding protein, enhances poly(ADP-ribose) polymerase-1 (PARP-1) activity and protects pancreatic cancer cells from DNA damage Genes Chromosom Cancer 50 13-24
  • [7] Su C(2006)Comparison of gene expression profiles between Hepatology 44 1025-1038
  • [8] O’Connor KW(2007) and non- Cancer Res 67 5117-5125
  • [9] Dejsuphong D(2006) associated human intrahepatic cholangiocarcinoma Int J Oncol 29 567-575
  • [10] Park E(2012)Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles BMC Genomics 13 535-W102
12345678910